Literature DB >> 3222228

Cytosolic epoxide hydrolase in human placenta.

R N Wixtrom1, M H Silva, B D Hammock.   

Abstract

It has been shown that cytosol from human term placenta contains cytosolic epoxide hydrolase activity. This cytosolic epoxide hydrolase was enriched more than 700-fold by affinity chromatography and appears similar to the enzyme from mouse and human liver in terms of molecular mass (Mr 59,000) and antigenic reactivity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3222228     DOI: 10.1016/0143-4004(88)90028-8

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  3 in total

1.  Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors.

Authors:  Danyan Xu; Ning Li; Yuxia He; Valeriy Timofeyev; Ling Lu; Hsing-Ju Tsai; In-Hae Kim; Dipika Tuteja; Robertino Karlo P Mateo; Anil Singapuri; Benjamin B Davis; Reginald Low; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-27       Impact factor: 11.205

2.  Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches.

Authors:  Ning Li; Jun-Yan Liu; Valeriy Timofeyev; Hong Qiu; Sung Hee Hwang; Dipika Tuteja; Ling Lu; Jun Yang; Hideki Mochida; Reginald Low; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  J Mol Cell Cardiol       Date:  2009-08-28       Impact factor: 5.000

3.  Transcriptional regulation of the human soluble epoxide hydrolase gene EPHX2.

Authors:  Hiromasa Tanaka; Shizuo G Kamita; Nicola M Wolf; Todd R Harris; Zhaoju Wu; Christophe Morisseau; Bruce D Hammock
Journal:  Biochim Biophys Acta       Date:  2007-12-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.